Baxter International | BAX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 81.92M 8.72M 2026-06
Avanos Medical USD 131.2M 34M 2026-03
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Fresenius EUR 8.38B 1.18B 2025-12
Globus Medical USD 482.46M 16.04M 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
ICU Medical USD 517.9M 19.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
J&J USD 54.9B 2.82B 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 264.93M 48.06M 2026-06
Quest Diagnostics USD 1.79B 389M 2026-06
Smith & Nephew USD 1.54B 236M 2025-12
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Terumo JPY 540.73B 1.03B 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03